Quick Answer
ACADIA PHARMACEUTICALS INC reported Stockholders Equity of $1.23 billion for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.23B | +67.5% |
| 2024 | $732.79M | +69.7% |
| 2023 | $431.75M | +7.8% |
| 2022 | $400.41M | -26.0% |
| 2021 | $540.89M | -13.7% |
| 2020 | $627.01M | -10.3% |
| 2019 | $699.13M | +45.9% |
| 2018 | $479.08M | +42.9% |
| 2017 | $335.29M | -35.3% |
| 2016 | $518.41M | +159.5% |
| 2015 | $199.76M | -35.5% |
| 2014 | $309.49M | +69.9% |
| 2013 | $182.13M | +114.3% |
| 2012 | $84.98M | +263.8% |
| 2011 | $23.36M | -21.3% |
| 2010 | $29.69M | +145.1% |
| 2009 | $12.11M | -77.1% |
| 2008 | $52.99M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $917.27M | +58.9% | +11.5% |
| June 30, 2025 | $822.38M | +59.2% | +7.5% |
| March 31, 2025 | $765.24M | +64.9% | +4.4% |
| December 31, 2024 | $732.79M | +69.7% | +27.0% |
| September 30, 2024 | $577.18M | +59.4% | +11.7% |
| June 30, 2024 | $516.70M | +30.5% | +11.3% |
| March 31, 2024 | $464.04M | +24.0% | +7.5% |
| December 31, 2023 | $431.75M | +7.8% | +19.2% |
- ACADIA PHARMACEUTICALS INC showed an increase of +67.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, ACADIA PHARMACEUTICALS INC’s stockholders equity has grown by 2216.2% (from $52.99 million to $1.23 billion).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: